The present invention relates to solid oral pharmaceutical compositions comprising cinacalcet or salts thereof. In particular, the present invention relates to solid oral pharmaceutical compositions comprising cinacalcet or salts thereof and at least one pharmaceutically acceptable excipient other than disintegrating agent. The invention further relates to a method of treating secondary hyperparathyroidism and hypercalcemia in patients in need thereof by using such compositions.